Kling Bio appointment of Dr Stefano Gullà as Chief Scientific Officer Kling Bio appointment of Dr Stefano Gullà as Chief Scientific Officer Experienced, innovative biotech and pharma leader with demonstrated success in discovery and development of new therapeutic technologies Dr Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma Dr Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma Rentschler Biopharma announces that Dr Günter Stempfer has been appointed Site Head of the company’s facility in Laupheim, Germany, effective 1 December 2023 Zenas BioPharma strengthens executive leadership team Zenas BioPharma strengthens executive leadership team Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications Poolbeg Pharma PLC announces directorate change Poolbeg Pharma PLC announces directorate change AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO AC Immune strengthens management, appoints Madiha Derouazi as CSO and Christopher Roberts as CFO Retiring CSO Dr. Marie Kosco-Vilbois will remain as consultant to ensure smooth handover Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping... Change of management at the Romaco facility in Karlsruhe Change of management at the Romaco facility in Karlsruhe Boris Bachmeier appointed new Managing Director of Romaco Pharmatechnik GmbH Aptar Digital Health expands oncology clinical advisory board Aptar Digital Health expands oncology clinical advisory board Aptar Digital Health announces the expansion of its oncology clinical advisory board. Cherwell welcomes new recruits as pharma environmental monitoring needs grow Cherwell welcomes new recruits as pharma environmental monitoring needs grow Autumn 2023 sees five new starters across Cherwell’s expanding business to support continuing business growth in cleanroom microbiology New expert advisory board appointments set to drive growth and innovation at Hongene New expert advisory board appointments set to drive growth and innovation at Hongene Hongene, a leading biotech company in the nucleic acid manufacturing sector, has launched a new advisory board with international experts from academia and industry. This... Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors Myricx Bio appoints Dr Chris Martin as Chair of its Board of Directors Dr Martin is a renowned biotech company founder, director and entrepreneur, and a pioneer and leader in the ADC space Axplora announces the appointment of its Scientific Advisory Board Axplora announces the appointment of its Scientific Advisory Board This SAB plays a key role in setting market trends and shaping Axplora Research & Development (R&D) activities, while supporting the deployment of innovative technologies and... Christian Praxmarer becomes new CEO of Single Use Support Christian Praxmarer becomes new CEO of Single Use Support Former Managing Director and COO, Christian Praxmarer, will become the new CEO of Single Use Support on 15 November Management changes at EyeC: Markus Fietkau is the new Sales Director Management changes at EyeC: Markus Fietkau is the new Sales Director Markus Fietkau will be responsible for sales management, whereas Ralph Beier will support the department as Business Development Director SENISCA strengthens board with the appointment of Dr David Chiswell as Chair SENISCA strengthens board with the appointment of Dr David Chiswell as Chair Highly experienced biotech veteran to support SENISCA’s rapid development of its senotherapeutic platform IO Biotech appoints Helen Collins, MD, to its board of directors IO Biotech appoints Helen Collins, MD, to its board of directors Dr Collins is an industry veteran with significant experience in oncology/haematology drug development and will serve on the Research and Development Committee of the board